Skip to main content

Table 9 Estimates of funds

From: Therapeutic effect of subcutaneous injection of low dose recombinant human granulocyte-macrophage colony-stimulating factor on pulmonary alveolar proteinosis

Medication method

Minimum Dose x Minimum Time

RMB (yuan)

Maximum Dose x Maximum Time

RMB (yuan)

Inhalation

250μg qd × 14 weeks, 4 days-on, 4 days-off

15,190

500μg bid*68 weeks

344,306

Subcutaneous injection

9μg/kg/day*12 weeks

32,811

18μg/kg/d*52 weeks

284,357

This method

75μg qd*6 months

7324

150μg qd*6 months

13,020